Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
11.39
-0.25 (-2.15%)
At close: Jun 30, 2025, 4:00 PM
11.29
-0.10 (-0.88%)
After-hours: Jun 30, 2025, 4:31 PM EDT
Nurix Therapeutics Market Cap
Nurix Therapeutics has a market cap or net worth of $868.32 million as of June 30, 2025. Its market cap has decreased by -16.46% in one year.
Market Cap
868.32M
Enterprise Value
368.90M
1-Year Change
-16.46%
Ranking
Category
Stock Price
$11.39
Market Cap Chart
Since July 24, 2020, Nurix Therapeutics's market cap has increased from $704.09M to $868.32M, an increase of 23.33%. That is a compound annual growth rate of 4.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 887.38M | -33.51% |
| Dec 31, 2024 | 1.33B | 166.61% |
| Dec 29, 2023 | 500.56M | -3.31% |
| Dec 30, 2022 | 517.68M | -59.92% |
| Dec 31, 2021 | 1.29B | 1.09% |
| Dec 31, 2020 | 1.28B | 81.45% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 217.42B |